scholarly journals Impact of the COVID-19 pandemic on drug-related problems and pharmacist interventions in geriatric acute care units

2021 ◽  
Author(s):  
Marion Chappe ◽  
Mathieu Corvaisier ◽  
Antoine Brangier ◽  
Cédric Annweiler ◽  
Laurence Spiesser-Robelet
Keyword(s):  
Acute Care ◽  
Drug Related Problems ◽  
Pharmacist Interventions

Methods used to attribute costs avoided from pharmacist interventions in acute care: A scoping review

2021 ◽  
Author(s):  
Sujita W Narayan ◽  
Ivo Abraham ◽  
Brian L Erstad ◽  
Curtis E Haas ◽  
Arthur Sanders ◽  
...  
Keyword(s):  
Acute Care ◽  
Scoping Review ◽  
Pharmacy Practice ◽  
Economic Implications ◽  
Medline Search ◽  
Cost Avoidance ◽  
Harmful Consequence ◽  
Pharmacist Interventions ◽  
Acute Care Settings ◽  
Human Participants

Abstract Purpose Cost-avoidance studies are common in pharmacy practice literature. This scoping review summarizes, critiques, and identifies current limitations of the methods that have been used to determine cost avoidance associated with pharmacists’ interventions in acute care settings. Methods An Embase and MEDLINE search was conducted to identify studies that estimated cost avoidance from pharmacist interventions in acute care settings. We included studies with human participants and articles published in English from July 2010 to January 2021, with the intent of summarizing the evidence most relevant to contemporary practice. Results The database search retrieved 129 articles, of which 39 were included. Among these publications, less than half (18 of 39) mentioned whether the researchers assigned a probability for the occurrence of a harmful consequence in the absence of an intervention; thus, a 100% probability of a harmful consequence was assumed. Eleven of the 39 articles identified the specific harm that would occur in the absence of intervention. No clear methods of estimating cost avoidance could be identified for 7 studies. Among all 39 included articles, only 1 attributed both a probability to the potential harm and identified the cost specific to that harm. Conclusion Cost-avoidance studies of pharmacists’ interventions in acute care settings over the last decade have common flaws and provide estimates that are likely to be inflated. There is a need for guidance on consistent methodology for such investigations for reporting of results and to confirm the validity of their economic implications.

Evaluation of Targeted Pharmacist Interventions to Reduce Length of Stay in an Acute Care Practice Model

2018 ◽  
Vol 53 (5) ◽  
pp. 471-477 ◽  
Author(s):  
Mary-Haston Leary ◽  
Kathryn Morbitzer ◽  
Bobbi Jo Walston ◽  
Stephen Clark ◽  
Jenna Kaplan ◽  
...  
Keyword(s):  
Length Of Stay ◽  
Acute Care ◽  
Positive Impact ◽  
Pharmacy Practice ◽  
Care Practice ◽  
Readmission Rates ◽  
A Value ◽  
Pharmacist Interventions ◽  
Semistructured Interviews ◽  
The Impact

Background: Despite widespread recognition of the need for innovative pharmacy practice approaches, the development and implementation of value-based outcomes remains difficult to achieve. Furthermore, gaps in the literature persist because the majority of available literature is retrospective in nature and describes only the clinical impact of pharmacists’ interventions. Objective: Length of stay (LOS) is a clinical outcome metric used to represent efficiency in health care. The objective of this study was to evaluate the impact of pharmacist-driven interventions on LOS in the acute care setting. Methods: A separate samples pretest-posttest design was utilized to compare the effect of pharmacist interventions across 3 practice areas (medicine, hematology/oncology, and pediatrics). Two time periods were evaluated: preimplementation (PRE) and a pilot period, postimplementation of interventions (POST). Interventions included targeted discharge services, such as discharge prescription writing (with provider cosignature). Participating pharmacists completed semistructured interviews following the pilot. Results: A total of 924 patients (466 PRE and 458 POST) were included in the analysis. The median LOS decreased from 4.95 (interquartile range = 3.24-8.5) to 4.12 (2.21-7.96) days from the PRE versus POST groups, respectively ( P < 0.011). There was no difference in readmission rates between groups (21% vs 19.1%, P = 0.7). Interviews revealed several themes, including positive impact on professional development. Conclusion and Relevance: This pilot study demonstrated the ability of pharmacist interventions to reduce LOS. Pharmacists identified time as the primary barrier and acknowledged the importance of leaders prioritizing pharmacists’ responsibilities. This study is novel in targeting LOS, providing a value-based outcome for clinical pharmacy services.

scholarly journals Drug related problems in admitted geriatric patients: The impact of clinical pharmacist interventions

2019 ◽  
Author(s):  
Berhane Yohannes Hailu ◽  
Derbew Fikadu Berhe ◽  
Esayas Kebede Gudina ◽  
Kidu Gidey ◽  
Mestwat Getachew
Keyword(s):  
Clinical Pharmacist ◽  
Geriatric Patients ◽  
Medical Center ◽  
Optimization Methods ◽  
Acceptance Rate ◽  
Drug Related Problems ◽  
Treatment Optimization ◽  
Pharmacist Interventions ◽  
Age Related ◽  
The Impact

Abstract Background: Geriatric patients are at high risk of Drug Related Problems (DRPs) due to multi- morbidity associated polypharmacy, age related physiologic changes, pharmacokinetic and pharmacodynamics alterations. These patients are often excluded from premarketing trials that can further increase the occurrence of DRPs. This study was aimed to identify DRPs and determinants in geriatric patients admitted to medical and surgical wards, and to evaluate the impact of clinical pharmacist interventions for treatment optimization. Methods: A prospective observational study was conducted among geriatric patients admitted to medical and surgical wards of Jimma University Medical Center from April to July 2017. Clinical pharmacists reviewed patients drug therapy, identified drug related problems and provided interventions. Data were analyzed by using SPSS statistical software version 20.0. Descriptive statistics were performed to determine the proportion of drug related problems. Logistic regression analyses were performed to identify the determinants of drug related problems. Results: A total of 200 geriatric patients were included in the study. The mean age of the participants was 67.3 years (SD7.3). About 82% of the patients had at least one drug related problems. A total of 380 drug related problems were identified and 670 interventions were provided. For the clinical pharmacist interventions, the prescriber acceptance rate was 91.7%. Significant determinants for drug related problems were polypharmacy (adjusted odds ratio [AOR]=4.350, 95% C.I: 1.212-9.260, p = 0.020) and number of comorbidities (AOR=1.588, 95% C.I: 1.029-2.450, p = 0.037). Conclusions: Drug related problems were substantially high among geriatric inpatients. Geriatric patients with polypharmacy and comorbidities need special attention to prevent drug related problems. Involving clinical pharmacist in the clinical team resulted in the improved acceptance rate of treatment optimization.

scholarly journals Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital

2016 ◽  
Vol 6 (5) ◽  
pp. 242-247 ◽  
Author(s):  
Alicia Gunterus ◽  
Shruti Lopchuk ◽  
Christina Dunn ◽  
Ronald Floyd ◽  
Brad Normandin
Keyword(s):  
Cost Saving ◽  
Economic Analysis ◽  
Acute Care ◽  
Psychiatric Hospital ◽  
Clinical Pharmacist ◽  
Hospital Setting ◽  
Medication Order ◽  
Cost Avoidance ◽  
Pharmacist Interventions ◽  
Medical Teams

Abstract Introduction: Clinical pharmacists have become an integral part of multidisciplinary medical teams, including in the area of psychiatry. Previous studies have shown that having pharmacists in multidisciplinary medical teams has led to improved medication use, reduction of adverse drug events, and improved patient outcomes. The purpose of this study is to conduct a quantitative and economic analysis of the impact of clinical pharmacist interventions during hospital rounds in an acute care psychiatric hospital setting. Methods: This is a retrospective analysis of 200 clinical pharmacist interventions documented between September 2013 and September 2014. Clinical pharmacist interventions were classified into several categories and types. Only clinical pharmacist interventions made during multidisciplinary team rounds were included in the study. Descriptive statistics were used for the quantitative analysis of clinical pharmacist interventions. The acceptance rate was calculated. Only the accepted clinical interventions were included in the economic analysis. Economic outcome involved an assessment of cost saving and cost avoidance. Results: The most frequent types of clinical pharmacist interventions were discontinuation of medications (38.5%), laboratory monitoring (26%), and medication order modification (13.5%). The most common reason for drug discontinuation was polypharmacy. Clinical pharmacist interventions were associated with a 92.5% acceptance rate. Two hundred clinical pharmacist interventions were associated with $6760.19 medication cost saving and $62 806.67 cost avoidance. Discussion: Clinical pharmacist interventions during rounds in an acute care psychiatric hospital setting mostly involve medication order modification and laboratory monitoring. They are also associated with significant cost saving and cost avoidance.

scholarly journals Clinical pharmacist interventions in managing Key Monitoring Drugs in China

2020 ◽  
Author(s):  
Jing Yang ◽  
Lei Zheng ◽  
Yuyao Guan ◽  
Xiaoli Zhang ◽  
Chao Song ◽  
...  
Keyword(s):  
Drug Cost ◽  
Clinical Pharmacist ◽  
Improve Patient Care ◽  
Scientific Management ◽  
Drug Related Problems ◽  
Pharmacist Interventions ◽  
Management Measures ◽  
Based Medicine ◽  
Improve Patient ◽  
Related Harm

Abstract Background Drug-related problems (DRPs) are common in hospitalized patients using Key Monitoring Drugs. Clinical pharmacy services could minimize drug-related harm and improve patient care.Objective The aim of this study was to standardize the clinical application of Key Monitoring Drugs, reduce the Drug-related problems (DRPs) and drug costs by clinical pharmacist interventions.Methods Clinical pharmacist formulate management measures for Key Monitoring Drugs using evidence-based medicine and analyze the DRPs of Key Monitoring Drugs over a period of 5 years from 2015 to 2019. The drug cost and DRPs of Key Monitoring Drugs within five years after interventions by clinical pharmacist.Results In 2019, the total cost of the use of Key Monitoring Drugs decreased by 10.12 million CNY, in comparison to that in 2015. The proportion of revenue from Key Monitoring Drugs decreased by 11.49% from 2015 to 2019. The per capita drug cost of Key Monitoring Drugs gradually decreased, this resulted in a saving of 580.07 CNY from 2015 to 2019. The DRPs of Key Monitoring Drugs decreased by 45.50% from 2015 to 2019. Through administrative intervention, prescription review, information management, and pharmaco-economicevaluation, a scientific management system of Key Monitoring Drugs has been established, which can standardize the use of Key Monitoring Drugs and reduce their cost. Conclusion Clinical pharmacists’ interventions assisted in early detection Drug-related problems of Key Monitoring Drugs and prevention of the consequent patient harms.

Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing

2013 ◽  
Vol 35 (5) ◽  
pp. 847-853 ◽  
Author(s):  
Mélina Raimbault-Chupin ◽  
Laurence Spiesser-Robelet ◽  
Véronique Guir ◽  
Cédric Annweiler ◽  
Olivier Beauchet ◽  
...  
Keyword(s):  
Electronic Prescribing ◽  
Drug Related Problems ◽  
Pharmacist Interventions ◽  
Geriatric Unit
Sign in / Sign up

Export Citation Format

Share Document